Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Arialys, Biogen, Biostar, Eisai, Nrx, Vertex.
Biopharma happenings, including deals and partnerships, and other news in brief: Cidara, Evaxion, Gossamer, Lunia Bioworks, Merck, Qurient, Respira, Synaffix, Tiziana, Verona.
Biopharmas raising money in public or private financings, including: Arecor, Drugs Made In America, Immuneering, Kalvista, Ligand, MBX, Pepgen, Sanofi.
The U.S. FDA released a trio of draft guidances to help sponsors in developing and monitoring cell and gene therapies, as well as other regenerative medicine therapies.
RSS
